Nutrien Reports Q1 2025 Results & Maintains FY Guidance
Nutrien Ltd. (TSX and NYSE: NTR) reported financial results for the first quarter ended March 31, 2025, with net earnings of $19 million, or $0.02 per diluted share.
Nutrien Ltd. (TSX and NYSE: NTR) reported financial results for the first quarter ended March 31, 2025, with net earnings of $19 million, or $0.02 per diluted share.
Loveland Products and Ascribe Bioscience are expanding their U.S. collaboration to include new Phytalix® premixes targeting row crops.
To provide the best experience, we use technologies like cookies to store and access device information.